StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics operating margin

Operating margin is operating income as a percentage of revenue.

Bionano Genomics's operating margin for the twelve months ending Jun 30, 2026 was -106.7%. For fiscal 2025 it was -116.9%, against -337.9% the year before. The highest annual figure on record is -116.9% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-116.9%+220.9
FY2024Dec 31, 2024-337.9%+258.1
FY2023Dec 31, 2023-596.0%−122.3
FY2022Dec 31, 2022-473.7%−44.9
FY2021Dec 31, 2021-428.8%+24.6
FY2020Dec 31, 2020-453.4%−197.9
FY2019Dec 31, 2019-255.4%−85.3
FY2018Dec 31, 2018-170.1%+74.2
FY2017Dec 31, 2017-244.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-88.3%+27.5
Q1 FY2026Mar 31, 2026-118.1%+13.0
Q4 FY2025Dec 31, 2025-107.4%+38.9
Q3 FY2025Sep 30, 2025-115.9%+607.0
Q2 FY2025Jun 30, 2025-115.8%+103.1
Q1 FY2025Mar 31, 2025-131.1%+223.8
Q4 FY2024Dec 31, 2024-146.3%+86.5
Q3 FY2024Sep 30, 2024-722.9%+492.1
Q2 FY2024Jun 30, 2024-219.0%+234.0
Q1 FY2024Mar 31, 2024-354.9%+155.4
Q4 FY2023Dec 31, 2023-232.7%+224.1
Q3 FY2023Sep 30, 2023-1215.0%−769.8
Q2 FY2023Jun 30, 2023-453.0%+28.0
Q1 FY2023Mar 31, 2023-510.4%+15.3
Q4 FY2022Dec 31, 2022-456.8%−0.1
Q3 FY2022Sep 30, 2022-445.2%−1.0
Q2 FY2022Jun 30, 2022-480.9%−53.7
Q1 FY2022Mar 31, 2022-525.7%−173.3
Q4 FY2021Dec 31, 2021-456.7%−177.9
Q3 FY2021Sep 30, 2021-444.2%+21.5
Q2 FY2021Jun 30, 2021-427.3%+201.7
Q1 FY2021Mar 31, 2021-352.4%+507.0
Q4 FY2020Dec 31, 2020-278.8%−22.1
Q3 FY2020Sep 30, 2020-465.7%−294.1
Q2 FY2020Jun 30, 2020-629.0%−314.4
Q1 FY2020Mar 31, 2020-859.3%−525.5
Q4 FY2019Dec 31, 2019-256.7%−104.8
Q3 FY2019Sep 30, 2019-171.6%+39.4
Q2 FY2019Jun 30, 2019-314.7%−196.3
Q1 FY2019Mar 31, 2019-333.8%−88.6
Q4 FY2018Dec 31, 2018-151.9%+32.2
Q3 FY2018Sep 30, 2018-211.0%−27.6
Q2 FY2018Jun 30, 2018-118.4%–
Q1 FY2018Mar 31, 2018-245.2%–
Q4 FY2017Dec 31, 2017-184.2%–
Q3 FY2017Sep 30, 2017-183.4%–

More Bionano Genomics figures

See a number that looks wrong?